NRXS
Neuraxis Inc (NRXS)
Healthcare • NYSE MKT • $8.20-6.82%
- Symbol
- NRXS
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $8.20
- Daily Change
- -6.82%
- Market Cap
- $94.34M
- Trailing P/E
- N/A
- Forward P/E
- -273.33
- 52W High
- $9.33
- 52W Low
- $2.04
- Analyst Target
- $11.00
- Dividend Yield
- N/A
- Beta
- 1.48
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is…
Company websiteResearch NRXS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.